PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

UNM researcher helps develop a molecule that illuminates nerve tissue, helping make surgery faster and safer.

2025-07-03
(Press-News.org) When surgeons dissect tissue to remove a tumor or make a repair they must work cautiously, relying on electrophysical monitors and their own anatomical knowledge to avoid cutting nerves, which could complicate the patient’s recovery.

A University of New Mexico surgeon has helped develop and test a first-of-its-kind drug that binds to nerve tissue and fluoresces – emits light – enabling surgeons to better see the nerves they’re trying to work around.

A newly published study in Nature Communications reported that bevonescein – a short chain of amino acids attached to a fluorescing molecule – was safe to use highlighted longer stretches of nerves than would be visible to the naked eye, improving the odds of operating without causing injury.

“The way that I explain this drug to patients is that I think if we can help surgeons see things better, they can do faster, more efficient, safer surgery,” said Ryan Orosco, MD, an associate professor and otolaryngologist (head and neck surgeon) in the UNM School of Medicine who co-authored the paper.

The journal article reported on a small Phase 1-2 study of the drug, which was tested on 27 cancer patients to evaluate its safety and efficacy. “The trial was for patients having a neck dissection to remove lymph nodes or a parotid surgery or a thyroid surgery,” he said. “In all of those cases, there are cranial nerves that are important to identify, work around and protect.”

A larger Phase 3 study currently underway includes patients at UNM Hospital and is expected to be completed by this summer, Orosco said. It will assess whether use of the imaging agent meaningfully improves overall surgical outcomes, something the initial trial was not designed to determine.

Orosco’s involvement in the development of the drug dates back to his ENT residency at the University of California, San Diego, where he spent a year-long research fellowship in the lab of Quyen Nguyen, MD, PhD. She had worked closely with the late biochemist Roger Tsien, PhD, who won the Nobel Prize in 2008 for discovering green fluorescent protein, enabling the development of methods to “tag” specific molecules and tissue types, such as cancer cells.

Nguyen’s research eventually led to the development of bevonescein, and Orosco, who went on to do a head and neck cancer fellowship at Stanford before joining the UCSD faculty, played a role in developing the clinical trial protocol and performed many of the surgeries in the study.

He joined the UNM faculty in late 2022 and now serves as the national principal investigator for the Phase 3 trial of the drug, which now includes 10 sites.

Patients in the trials receive an IV infusion of the drug prior to surgery, but it is quickly cleared by the kidneys, Orosco said. “We can image them five, six, seven, eight hours later, and it still stays bound to the nerves, but it flushes out of the body within 12 hours.”

In the operating room, surgeons use microscopes with special lights and filters that illuminate the surgical site at a specific frequency that causes the drug to fluoresce. The nerves appear as wormlike yellowish-green structures that thread through the surrounding tissue.

An upcoming phase of the research will evaluate the use of specially modified headband-mounted magnifying loops of the sort that surgeons wear, rather than the microscope. “Testing those loops in a spinoff trial is a critical and practical step toward real-world implementation,” Orosco said.

If the Phase 3 trial shows clear clinical benefit from the use of bevonescein during head and neck surgery it could win FDA approval, leading to wider use in surgical procedure throughout the body. “Once the FDA has approved it for a certain indication, then it'll be on the shelves,” he said. “Surgeons can also use it off-label for whatever they want. Then the big question is, how does that go? Who starts using it and in which types of surgeries?”

END


ELSE PRESS RELEASES FROM THIS DATE:

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

2025-07-03
The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer (PC). The study, conducted by a team of researchers from the University of Chinese Academy of Sciences and Chongqing Medical University, has established a prognostic model that links EMP1 expression with adverse clinical outcomes, particularly among older PC patients.   Pancreatic cancer remains a highly aggressive ...

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

2025-07-03
  A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression. The research, conducted by scientists from Chongqing Medical University, identifies XPR1 as a critical factor influencing the aggressiveness of ovarian cancer through its interaction with LAMP1 and the PI3K/Akt/mTOR signaling pathway. These findings shed light on new therapeutic targets for ovarian cancer, a malignancy known for its poor prognosis and resistance to immune checkpoint inhibitors.   The ...

Flexible, eco-friendly electronic plastic for wearable tech, sensors

2025-07-03
CLEVELAND—Researchers at Case Western Reserve University have developed an environmentally safer type of plastic that can be used for wearable electronics, sensors and other electrical applications. The material, a so-called ferroelectric polymer, is made without fluorine, considered a “forever” chemical that hurts the environment because compounds made with it don’t break down quickly or at all. Although the researchers are still working to improve the material’s electric and elastic properties, the potential is vast for its flexibility of electronic uses and eco-friendly structure. “How this material ...

Can the Large Hadron Collider snap string theory?

2025-07-03
Key takeaways Researchers from Penn and Arizona State University pinpoint a lone five-particle package (a 5-plet) that could upend string theory by detecting it at the Large Hadron Collider. “Ghost” tracks that vanish mid-flight may be the smoking gun physicists are chasing. Early data squeeze the search window, but the next collider runs could make—or break—the case. In physics, there are two great pillars of thought that don’t quite fit together. The Standard Model of particle physics describes all known fundamental particles and three forces: electromagnetism, ...

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

2025-07-03
UNIVERSITY PARK, Pa. — Alexandra Staub, author and professor of architecture in the College of Arts and Architecture’s Stuckeman School at Penn State, examines how architects can better serve society by changing their approach to the building process in her latest book titled “Architecture and Social Sustainability: Understanding the New Paradigm.” Published by Routledge, the book presents examples of “how we can better design for stakeholder agency, serve historically marginalized populations, and further our theoretical thinking about sustainability writ large,” according to the book’s ...

Synthetic DNA nanoparticles for gene therapy

2025-07-03
CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA nanoparticles, which have potential applications in gene therapy. The grant will support Mathur’s work in synthesizing nanoparticles and studying how they behave inside cells in a laboratory. She will use single-cell injections and a microscope to track the nanoparticles and watch what happens to them over time ...

New model to find treatments for an aggressive blood cancer

2025-07-03
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found.   In a paper published in Nature Communications a team of researchers led from the University of Birmingham have studied blood cells from patients with a blood cancer called myelodysplastic syndrome disease (MDS). This disease often develops into a highly aggressive form of Acute Myeloid Leukaemia (AML).   Working with this new model ...

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

2025-07-03
Acute hypoxemic respiratory failure (AHRF) represents one of the most common yet challenging conditions treated in intensive care units (ICUs) worldwide. While the emergence of multiple options for non-invasive respiratory support has revolutionized care in such cases, selecting the optimal approach remains difficult. Now, a special issue from the Journal of Intensive Medicine titled “Non-invasive respiratory support for acute hypoxemic respiratory failure” provides key insights to guide these critical treatment decisions. This collection establishes a robust foundation for understanding the key respiratory support ...

T cells take aim at Chikungunya virus

2025-07-03
LA JOLLA, CA—A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus trigger the strongest response from the body's T cells.  With this map in hand, researchers are closer to developing Chikungunya vaccines or therapies that harness T cells to strike specific targets, or "epitopes," to halt infection. The new study also offers important clues for understanding why many people experience chronic, severe joint pain for years after clearing the virus. "Now we can see what T cells are seeing patients with chronic disease," says LJI Assistant Professor ...

Gantangqing site in southwest China yields 300,000-year-old wooden tools

2025-07-03
  New discoveries from the Pleistocene-age Gantangqing site in southwestern China reveal a diverse collection of wooden tools dated from ~361,000 to 250,000 years ago, marking the earliest known evidence of complex wooden tool technology in East Asia. The findings reveal that the Middle Pleistocene humans who used these tools crafted the wooden implements not for hunting, but for digging and processing plants. Although early humans have worked with wood for over a million years, wooden artifacts are quite rare in the archaeological ...

LAST 30 PRESS RELEASES:

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

T cells take aim at Chikungunya virus

Gantangqing site in southwest China yields 300,000-year-old wooden tools

Forests can’t keep up: Adaptation will lag behind climate change

Sturgeon reintroduction initiative yields promising first-year survival rate

Study: Babies’ poor vision may help organize visual brain pathways

Research reveals Arctic region was permafrost-free when global temperatures were 4.5˚ C higher than today

Novel insights into chromophobe renal cell carcinoma biology and potential therapeutic strategies

A breakthrough in motor safety: AI-powered warning system enhances capability to uncover hidden winding faults

Research teases apart competing transcription organization models

Connect or reject: Extensive rewiring builds binocular vision in the brain

Benefits and risks: informal use of antibiotics to prevent sexually transmitted infections on the rise in key populations in the Netherlands

New molecular tool sheds light on how cancer cells repair telomeres

First large-scale stem cell bank enables worldwide studies on genetic risk for Alzheimer’s disease

Hearing devices significantly improve social lives of those with hearing loss

CNIC scientists reveal how the cellular energy system evolved—and how this knowledge could improve the diagnosis of rare genetic diseases

AI sharpens pathologists' interpretation of tissue samples

[Press-News.org] UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery
UNM researcher helps develop a molecule that illuminates nerve tissue, helping make surgery faster and safer.